Publication:
Highlights of the 8th Drug Hypersensitivity Meeting: Amsterdam, April 19-21, 2018.

dc.contributor.authorTorres, Maria J
dc.contributor.authorFernandez, Tahia D
dc.contributor.funderInstitute of Health “Carlos III” of the Ministry of Economy and Competitiveness
dc.contributor.funderEuropean Regional Development Fund (ERDF)
dc.contributor.funderRETICSARADyAL
dc.contributor.funderAndalusian Regional Ministry of Economy and Knowledge
dc.contributor.funderAndalusian Regional Ministry Health
dc.date.accessioned2023-01-25T10:21:04Z
dc.date.available2023-01-25T10:21:04Z
dc.date.issued2018-10-29
dc.description.abstractDrug hypersensitivity is a worldwide health problem that has gained importance in the last years due to the increased number of patients labeled as drug allergic, especially to antibiotics, and to the onset of allergy to new drugs such as biologicals and chemotherapy. The 8th Drug Hypersensitivity Meeting (DHM), organized by the European Academy of Allergy and Clinical Immunology (EAACI), took place in Amsterdam in 2018. DHM8 brought together international experts from different disciplines, including allergists, dermatologists, pharmacologists, immunologists, biologists, chemists, and toxicologists, for exchanging their valuable knowledge. The aim of the meeting was to progress in the understanding of the underlying mechanisms and to improve the diagnosis and management of drug hypersensitivity.
dc.description.sponsorshipThis study has been supported by Institute of Health “Carlos III” ofthe Ministry of Economy and Competitiveness (grants cofunded byEuropean Regional Development Fund (ERDF): PI15/01206, RETICSARADyAL RD16/0006/0001, and by Andalusian Regional Ministry ofEconomy and Knowledge (grants cofunded by European RegionalDevelopment Fund (ERDF): CTS‐06603); Andalusian Regional Min-istry Health (PI‐0241‐2016), TDF holds a “Ramon y Cajal” researchcontract by the Ministry of Economy and Competitiveness cofundedby European Social Fund (grant number RYC‐2013‐01283
dc.description.versionSi
dc.identifier.citationTorres MJ, Fernández TD. Highlights of the 8th Drug Hypersensitivity Meeting: Amsterdam, April 19-21, 2018. Allergy. 2018 Oct;73(10):1941-1943
dc.identifier.doi10.1111/all.13574
dc.identifier.essn1398-9995
dc.identifier.pmid30043992
dc.identifier.unpaywallURLhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.13574
dc.identifier.urihttp://hdl.handle.net/10668/12751
dc.issue.number10
dc.journal.titleAllergy
dc.journal.titleabbreviationAllergy
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.organizationCentro Andaluz de Nanomedicina y Biotecnología-BIONAND
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number1941-1943
dc.provenanceRealizada la curación de contenido 24/02/2025
dc.publisherJohn Wiley and Sons
dc.pubmedtypeEditorial
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.projectIDPI15/01206
dc.relation.projectIDRD16/0006/0001
dc.relation.projectIDCTS‐06603
dc.relation.projectIDPI‐0241‐2016
dc.relation.projectIDRYC‐2013‐01283
dc.relation.publisherversionhttps://doi.org/10.1111/all.13574
dc.rights.accessRightsRestricted Access
dc.subjectAnti-Bacterial Agents
dc.subjectAllergists
dc.subjectDermatologists
dc.subjectHypersensitivity
dc.subjectDrug Hypersensitivity
dc.subject.decsHipersensibilidad
dc.subject.decsPreparaciones farmacéuticas
dc.subject.decsDermatólogos
dc.subject.decsHipersensibilidad a las drogas
dc.subject.decsAntibacterianos
dc.subject.decsProductos biológicos
dc.subject.decsAlergólogos
dc.subject.meshAnaphylaxis
dc.subject.meshCongresses as Topic
dc.subject.meshDrug Hypersensitivity
dc.subject.meshHLA Antigens
dc.subject.meshHumans
dc.titleHighlights of the 8th Drug Hypersensitivity Meeting: Amsterdam, April 19-21, 2018.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number73
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format